Read the December 2018 Digital Edition
The December 2018 Digital Edition features the inaugural class of Best Places to Work, Outlook 2019, and more.
Print Issue: December 01, 2018
Marketers in the rare diseases area discuss trends to optimize efforts
What existing and future trends do marketers in the rare diseases area need to be mindful of to optimize their efforts?
4 startups outline their vision for the future of health tech in 2019
Investment in digital health companies shattered all existing records during 2018 — and startups in the behavioral health area snagged a good deal of it.
Focus on drugs’ cost may prevent their discovery
Breakthrough drugs will eventually be more affordable, but a misplaced focus on their cost may prevent them from being discovered at all.
How the pharma industry may be impacted by drug pricing and other policies in 2019
Now that the political climate lends itself to action on drug pricing, the days of pharma nirvana may be coming to an end. Here’s a look at the policy considerations likely to vex the industry in the year ahead.
AbelsonTaylor’s Amanda Hartzmark on martial arts, career lessons learned, and how she starts her day
Amanda Hartzmark is director of business development and analysis at AbelsonTaylor.
6 campaigns that empower the next generation to create a healthier future
Robin Davenport, EVP, executive creative director at Sudler, believes marketers and communicators must take an active role in creating a healthier future.
Infographic | What patients want from HCPs
Not surprisingly, transparency and personalization top the list of patient priorities.
The 2019 pipeline report: Changing the treatment paradigm
Are today’s developmental drugs tomorrow’s blockbusters? We survey what’s ahead for top candidates in six therapeutic categories.
These agencies found their golden mean in a mix of fun and professionalism
Maintaining and upping their internal fun quotient can help healthcare agencies cultivate people who will carry on the great legacy of marketing firms as the quintessential partners.
